Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant…
The Phase-2 clinical trial of Ropanicant (SUVN-911) is for the treatment of moderate to severe Major Depressive Disorder (MDD)…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Suven
Suven secures 4 patents for NCE’s in China, Mexico and SA
The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being developed as…
Suven gets three product patents in Israel, Macau and US
The patents are for the treatment of disorders associated with Neurodegenerative diseases
Suven secures one product patent each in Mexico and Singapore
These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research…
Suven Life secures five product patents for their NCEs in Israel, Japan, China and New Zealand
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven